Navigation Links
Mindray Medical International Announces Second Quarter 2008 Results
Date:9/3/2008

-- (6,600) -- (6,600)

Other general expenses (18) (7) (23) (13)

Operating income 21,260 27,816 37,320 55,716

Other income, net (9) 1,122 399 1,624

Interest income 2,525 2,171 4,788 4,529

Interest expense 9 (955) (3) (960)

Income before income

taxes and minority

interests 23,785 30,154 42,504 60,909

Provision for income

taxes (3,422) (6,097) (6,369) (11,800)

Minority interests -- 0 -- 0

Net Income 20,363 24,057 36,135 49,109

Basic earnings per

share 0.19 0.22 0.34 0.46

Diluted earnings per

share 0.18 0.21 0.32 0.43

Shares used in the

computation of:

Basic earnings per

share 106,163,849 107,263,477 105,962,395 107,113,068

Diluted earnings per

share 112,122,314 113,800,224 111,920,859 113,399,242

(2) Share-based

compensation charges

incurred during the

period related to:

Cost of revenues 56 111 101 221

Selling expenses 706 811 1,337 1,616

General and

administrative

expenses 587 659 1,105 1,230

Research and

development expenses 519 770 1,035 1,518

MINDRAY MEDICAL INTERNATIONAL LIMITED RECONCILIATIONS OF NON-GAAP RESULTS OF OPERATIONS MEASURES TO THE NEAREST

COMPARABLE GAAP MEASU
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
2. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
3. Mindray Medical International Announces Third Quarter 2007 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. Mindray Medical International Announces First Quarter 2008 Results
6. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
7. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
10. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
11. BioMS Medical announces its intention to renew a normal course issuer bid
Post Your Comments:
*Name:
*Comment:
*Email: